Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...

The weight loss drugs, by mimicking gut hormones, effectively reduce appetite and promote weight loss, which can in turn ...

Experts suggest that weight-loss jabs may require long-term use to achieve lasting benefits for both patients and the NHS.

Obesity — like most other medical conditions — requires an “arsenal” of treatments, rather than a one-size-fits-all approach.

Weight-loss jabs may need to be taken for life, experts warn - Professor Graham Easton said much like blood pressure drugs, ...

In South Carolina, the state Medicaid agency estimates only 1,300 beneficiaries will meet the stringent prerequisites for GLP ...

The European Medicines Agency said an eye condition that might cause loss of vision is a very rare side effect of Novo Nordisk's blockbuster drugs Ozempic and Wegovy.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...

Use of the weight-loss drug is rising among adolescents, but questions remain over long-term safety, access, and ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...